News & Press Releases

Mintz advised Axoft, a neurotechnology company, on a $55 million Series A financing round. The funding will be used to expand Axoft’s clinical trials globally and progress US regulatory approval for its implantable Brain-Computer Interfaces (iBCIs).  

Mintz has been recognized by US News & World Report as a 2026 Best Company to Work For among US law firms, marking the third consecutive year the firm has earned this distinction.

Mintz advised Potentia Inc. (Potentia), a leading developer of large-scale technology and energy infrastructure, on the closing today of its investment in Heartland Industrial Park, a major technology infrastructure development located in Sullivan County, Indiana.

Sige Gutman, Chair of Mintz’s Life Sciences Litigation Practice, was quoted in an Endpoints News article examining Supreme Court oral arguments on the limits of “skinny label” drug marketing and potential patent infringement liability for generic manufacturers.

Mintz advised the placement agents in the $145 million private placement of First Tracks Biotherapeutics’ common stock, which included $80 million of common stock sold by First Tracks Biotherapeutics and $65 million of common stock sold by a selling stockholder. The private placement was in connection with the spin-off of First Tracks Biotherapeutics from AnaptysBio.

New York – Mintz announces the appointment of Francis (Frank) Earley as Managing Member of its New York office. A seasoned litigator, Frank brings extensive experience handling complex commercial and securities disputes. He succeeds Stephen (Steve) Gulotta, who, after successfully leading the office for 17 years, will now focus full time on his role as Member in the firm’s Corporate & Securities Practice based in New York.